ICON Plc

ICON Plc ICON is a global provider of outsourced clinical research development services to the pharmaceutical, biotechnology, and medical device industries.

We help our clients accelerate the development of life-saving drugs that improve patients' quality of life.

Join ICON Biotech at CTO East Coast 2026, taking place 30 June – 1 July at the Boston Marriott Burlington, MA. Meet our ...
24/06/2026

Join ICON Biotech at CTO East Coast 2026, taking place 30 June – 1 July at the Boston Marriott Burlington, MA. Meet our team at Booth #18 to learn how our specialised clinical development services support biotech programs via flexible engagement models designed to adapt to evolving scientific and operational needs.

Join Padma Varadharajan on 30 June at 11:45am for her core session entitled: “Practical considerations for navigating the landscape of global oncology trials in 2026 and beyond.” This presentation will explore the operational, regulatory, and strategic realities shaping global oncology trials, plus what sponsors need to stay future ready in an increasingly complex environment. https://ow.ly/fmby50YUsMo

Recent regulatory shifts have critical implications for how biosimilar developers generate and prioritise information. R...
23/06/2026

Recent regulatory shifts have critical implications for how biosimilar developers generate and prioritise information. Read ICON’s latest article in PharmTech Magazine, to learn what these changes mean for data collection strategy, such as analytical comparability testing and bioanalytical methodologies. https://ow.ly/AB5R50Z7TC3

ICON will be attending , taking place from 3 - 4 July in Shanghai, China. Stop by booth #6 to connect with our team an...
22/06/2026

ICON will be attending , taking place from 3 - 4 July in Shanghai, China.
Stop by booth #6 to connect with our team and discover how ICON is transforming clinical research with innovative, data-driven solutions. Get a firsthand look at our cutting-edge technologies and gain insights from our industry experts.
We look forward to connecting and exploring collaboration opportunities to shape the future of clinical development https://ow.ly/8hrQ50ZeF5L

Osivelotor is an oral investigational drug for the treatment of sickle cell disease (SCD) designed to inhibit hemoglobin...
22/06/2026

Osivelotor is an oral investigational drug for the treatment of sickle cell disease (SCD) designed to inhibit hemoglobin polymerization. In a phase 1, open-label ADME study conducted in healthy participants at ICON’s clinical research unit in the Netherlands, a single 200 mg dose (including a 14C mictotracer) demonstrated slow elimination, with a half-life of approximately 27–30 days and almost 90% recovery in urine and f***s over nearly seven months months with six completers. The treatment was well tolerated, with the drug predominantly circulating unchanged in whole blood and glucuronide metabolite presence in plasma. These findings provide important insights into osivelotor’s absorption, metabolism, and excretion, supporting its continued development as a potential treatment for SCD. Read more here: https://ow.ly/TieG50Z7TtP

The EU Packaging & Packaging Waste Regulation is set to transform packaging requirements across Europe.For pharmaceutica...
19/06/2026

The EU Packaging & Packaging Waste Regulation is set to transform packaging requirements across Europe.

For pharmaceutical companies, this means new expectations for labelling, sustainability and lifecycle management.

Our latest article outlines what PPWR covers and how organisations can prepare.

Read more: https://ow.ly/UNUk50ZcNHa

From platform knowledge to continuous manufacturing, updated biologics guidance is influencing how viral safety is demon...
18/06/2026

From platform knowledge to continuous manufacturing, updated biologics guidance is influencing how viral safety is demonstrated across development and production.

This piece explores what these changes mean on the manufacturing floor and how teams can prepare for what’s next. Read the article on PharmTech to learn more. https://ow.ly/iKP750Z7neP

Real-time clinical trials could mark a significant shift in how clinical evidence is generated and shared.With the FDA l...
17/06/2026

Real-time clinical trials could mark a significant shift in how clinical evidence is generated and shared.

With the FDA leading early pilots, the opportunity to accelerate decision-making is clear, but how this approach translates globally remains an open question.

Explore what this means for trial design, data governance and regulatory engagement in our latest blog: https://ow.ly/fNkn50ZclgJ

Bringing drug-device combination products to market is becoming increasingly complex.In Pharma Focus Asia, our latest ar...
17/06/2026

Bringing drug-device combination products to market is becoming increasingly complex.

In Pharma Focus Asia, our latest article explores how evolving regulatory expectations are shaping development strategies and what sponsors need to consider when aligning drug and device components. Read the full article https://ow.ly/mpmJ50ZbSBv

Since 2024, new guidance from the FDA and EMA has advanced efforts to streamline biosimilar development to enhance comme...
17/06/2026

Since 2024, new guidance from the FDA and EMA has advanced efforts to streamline biosimilar development to enhance commercial appeal for developers. Explore the implications of new regulatory guidance and publications, including their impact on data generation and the competitive landscape, in this contributing article by our Head of the Centre for Biosimilar Drug Development, Kim Salgado. https://ow.ly/blgy50Z7Tya

Address

South County Business Park, Leopardstown
Dublin
18

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+35312912000

Website

Alerts

Be the first to know and let us send you an email when ICON Plc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ICON Plc:

Shortcuts

Featured

Share

Category